Kamini Raghuram | Drug Safety and Risk Management | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Kamini Raghuram | Drug Safety and Risk Management | Best Researcher Award

Staff Neonatologist and Developmental Pediatrician at University of Toronto | Canada

Dr. Kamini Raghuram is a clinician-scientist specializing in developmental and behavioral pediatrics, neonatal-perinatal medicine, and clinical epidemiology. With a strong foundation in pediatrics, she has combined clinical expertise with cutting-edge research to advance outcomes in high-risk and preterm infants. Her work bridges clinical practice, epidemiology, and innovative technological tools such as automated video-based analysis for motor impairment. Dr. Raghuram has been a principal and co-investigator on numerous funded projects and has published extensively in leading pediatric and neonatal journals. She is widely recognized for her dedication to improving long-term neurodevelopmental outcomes in vulnerable infant populations.

Publication Profile 

Orcid

Education 

Dr. Kamini Raghuram completed her Doctor of Medicine (MD) at the University of Toronto, followed by FRCPC training in General Pediatrics, Neonatal and Perinatal Medicine, and Developmental and Behavioral Pediatrics at the same institution. She earned a Master of Science in Clinical Epidemiology and Health Care Research from the Institute of Health Policy, Management, and Evaluation, University of Toronto, where her thesis focused on video-based motor impairment analysis in preterm infants. Earlier, she obtained a Bachelor of Applied Science in Chemical and Biological Engineering from the University of British Columbia, graduating as class valedictorian and recognized for outstanding research proficiency.

Experience 

Dr. Kamini Raghuram has held extensive clinical and academic positions across pediatrics, neonatology, and developmental medicine. She has served as a clinician-investigator, integrating patient care with translational research to develop evidence-based approaches for preterm infants. Her work includes leading clinical trials, advancing quality improvement initiatives, and applying machine learning and automated video analysis for early detection of motor and neurodevelopmental impairments. With expertise spanning neonatal intensive care, developmental follow-up, and health outcomes research, she has collaborated nationally and internationally to improve clinical pathways for high-risk infants. Her experience reflects a unique combination of bedside practice and pioneering research in pediatrics.

Awards and Honors 

Dr. Kamini Raghuram has received numerous awards and funding recognitions for her research and clinical excellence. These include CIHR grants exceeding $2 million, innovation fund competitions, and recognition for her work on neonatal outcomes. She has won presentation and research awards at the University of Toronto, The Hospital for Sick Children, and international conferences. Honors such as the Excellence in Academic Coaching Award, Quality Improvement Award, Canada Graduate Scholarship, and early-career fellowships highlight her leadership and academic impact. Earlier, as an engineering student, she received the Lefevre Gold Medal and delivered the valedictorian address at the University of British Columbia.

Research Focus 

Dr. Kamini Raghuram research focuses on improving neurodevelopmental and health outcomes in preterm and high-risk infants through early detection, intervention, and long-term follow-up strategies. She applies advanced tools, including automated video analysis, MRI biomarkers, and large-scale database studies, to identify predictors of motor and cognitive impairment. Her work integrates clinical epidemiology with neonatal and developmental pediatrics, emphasizing translational approaches from bench to bedside. She is also involved in clinical trials addressing interventions such as coadministration therapies and surgical decision-making in fetal medicine. Her ultimate goal is to enhance early diagnosis, optimize interventions, and improve quality of life for vulnerable children.

Publication Top Notes

Caregiver Experiences, Healthcare Provider Perspectives and Child Outcomes with Virtual Care in a Neonatal Neurodevelopmental Follow-Up Clinic: A Mixed-Methods Study

Automated Movement Analysis to Predict Cerebral Palsy in Very Preterm Infants: An Ambispective Cohort Study

Conclusion

Dr. Kamini Raghuram is a highly deserving candidate for the Best Researcher Award. Her career reflects a rare combination of clinical excellence, research innovation, and dedication to improving outcomes for preterm infants. With substantial grant funding, groundbreaking studies in automated movement analysis, and leadership in advancing neonatal care, she exemplifies the qualities of a leading researcher. While opportunities exist to expand her global influence and further scale her innovations, her proven track record of impactful, patient-centered research makes her an outstanding nominee for this prestigious recognition.

Dr. Michel Fares|Drug analysis|Best Researcher Award

Published on by Top Pharmaceutical

Dr. Michel Fares|Drug analysis|Best Researcher Award

Dr. Michel Fares at Nahda University,Egypt

PROFILE  

scopus

Orcid

Google scholar

 

 

Early Academic Pursuits 📚

Michel Yousry Fares embarked on his academic journey with a strong foundation in pharmaceutical sciences, receiving his Bachelor of Pharmacy degree from Nahda University in Beni Suef, Egypt, in 2013. Graduating with honors and a high GPA of 3.89, he demonstrated an early commitment to excellence in his field. His passion for analytical chemistry led him to pursue a Master’s degree in Pharmaceutical Analytical Chemistry at Beni Suef University, where he further honed his skills and knowledge. In 2022, Michel earned his Ph.D. in Pharmaceutical Analytical Chemistry from Cairo University, solidifying his expertise in the analytical methods used to assess pharmaceutical compounds.

Professional Endeavors 🏫

Currently, Michel serves as a Lecturer in the Pharmaceutical Analytical Chemistry Department at Nahda University’s Faculty of Pharmacy, a position he has held since 2022. In this role, he teaches a variety of undergraduate courses, including Pharmaceutical Analytical Chemistry, Instrumental Analysis, and Quality Control of Pharmaceuticals. His responsibilities also extend to research activities in the field of analytical chemistry, where he contributes to advancing the understanding and application of various analytical techniques, such as chromatography and spectroscopy. Michel also plays a key role in mentoring and advising students, helping shape the future of aspiring pharmaceutical professionals.

Beyond his teaching responsibilities, Michel serves as the Vice President of Electronic Learning Support (ELS) at Nahda University, where he has been instrumental in developing and maintaining the university’s e-learning platform, Moodle. His efforts in training instructors and resolving technical issues have significantly enhanced the educational experience for both faculty and students at the university.

Contributions and Research Focus 🔬

Michel’s primary research interests lie in the field of pharmaceutical analytical chemistry, with a specific focus on drug analysis, bioanalysis, and the development of innovative analytical techniques. He has authored several research articles and reviews, including a prominent piece on miniaturized solid-phase extraction techniques for analyzing various pollutants. This work highlights his commitment to advancing analytical methods for environmental and pharmaceutical applications.

His research endeavors also extend to the study of pharmacokinetic parameters, quality assurance, and experimental design. By applying a range of analytical techniques, Michel contributes to improving the quality and safety of pharmaceutical products. His focus on practical applications of pharmaceutical analysis aims to bridge the gap between theoretical knowledge and real-world problem-solving in the pharmaceutical industry.

Accolades and Recognition 🏅

Michel’s contributions to both research and education have not gone unnoticed. He was honored with the “Best Research Publishing Record in the Teaching Assistant Category” in 2022 at Nahda University, a testament to his dedication to advancing scientific knowledge. In 2021, he received the “Best Scientific Research in the Field of Applied Pharmaceutical Sciences” award from ACDIMA (The Arab Company for Drug Industries and Medical Appliances), further cementing his reputation as a leading figure in his field.

Michel’s contributions extend beyond the classroom and laboratory, as he has been actively involved in organizing and participating in scientific conferences. Notably, he was a key participant in the 3rd International Conference of the Faculty of Pharmacy at Ain Shams University and the 2nd International Conference of Pharmaceutical & Therapeutical Science in 2023, where he presented on topics such as online education and creativity in analytical chemistry.

Impact and Influence 🌍

Through his work in both academia and research, Michel has had a profound impact on the field of pharmaceutical sciences. His innovative research has contributed to the development of more efficient and accurate analytical methods, particularly in drug analysis and bioanalysis. As a teacher, he has shaped the careers of many future pharmacists and analytical chemists, emphasizing the importance of precision and quality in pharmaceutical testing.

Michel’s influence extends beyond his direct teaching and research contributions. He has been a reviewer for several prestigious scientific journals, including TrAC Trends in Analytical Chemistry and Journal of Pharmaceutical and Biomedical Analysis, where his expertise helps shape the direction of future research in the field.

Legacy and Future Contributions 🌱

Michel’s legacy is one of dedication to the advancement of pharmaceutical sciences and the education of the next generation of professionals. His work in the development of analytical techniques has had a lasting impact on both the academic and pharmaceutical industries, and his commitment to improving the quality of education will continue to benefit students for years to come.

Looking forward, Michel plans to continue his research into novel analytical methods, with a focus on environmental applications and the use of cutting-edge technologies like electrochemistry and chromatography. His goal is to contribute to the development of sustainable practices within pharmaceutical analysis, ensuring that future generations of scientists have the tools they need to meet the evolving challenges of the global pharmaceutical industry.

In addition to his research, Michel is committed to furthering his role in educational leadership, particularly in the integration of digital technologies into the learning process. He envisions a future where e-learning systems are more widely adopted, creating a more accessible and flexible learning environment for students around the world.

Conclusion ✨

Michel Yousry Fares stands out as a dedicated educator, researcher, and leader in the field of pharmaceutical analytical chemistry. His career is characterized by his commitment to excellence in both teaching and research, his impact on the development of analytical methods, and his dedication to shaping the future of pharmaceutical sciences. Through his ongoing work, Michel will continue to leave a positive and lasting legacy in the field, inspiring future generations of scientists and educators.

🎓Publication 

Green analytical chemistry as an integral part of sustainable education development

  • Authors   : Justyna Płotka-Wasylka, Heba M Mohamed, Aleksandra Kurowska-Susdorf, Rajkumar Dewani, Michel Y Fares, Vasil Andruch
  • Journal    :Current Opinion in Green and Sustainable Chemistry
  • Year         :2021

Determination of the abused intravenously self-administered madness drops (Tropicamide) by liquid chromatography in rat plasma; an application to pharmacokinetic study and …

  • Authors   : Maha M Abdelrahman, Nada S Abdelwahab, Maha A Hegazy, Michel Y Fares, Ghada M EL-Sayed
  • Journal    : Microchemical Journal
  • Year         :2020

Determination of sofosbuvir with two co-administered drugs; paracetamol and DL-methionine by two chromatographic methods. Application to a pharmacokinetic study

  • Authors   :Michel Y Fares, Nada S Abdelwahab, Maha M Abdelrahman, Hamdy M Abdel-Rahman
  • Journal    : Bioanalysis
  • Year         :2019

Miniaturized solid phase extraction techniques for different kind of pollutants analysis: state of the art and future perspectives–PART 1

  • Authors   : Justyna Płotka-Wasylka, Natalia Jatkowska, Monika Paszkiewicz, Magda Caban, Michel Y Fares, Aysegul Dogan, Salvador Garrigues, Natalia Manousi, Natasa Kalogiouri, Paweł Mateusz Nowak, Victoria F Samanidou, Miguel de la Guardia
  • Journal    :TrAC Trends in Analytical Chemistry
  • Year         :2023

Quality by design approach for green HPLC method development for simultaneous analysis of two thalassemia drugs in biological fluid with pharmacokinetic study

  • Authors   : Michel Y Fares, Maha A Hegazy, Ghada M El-Sayed, Maha M Abdelrahman, Nada S Abdelwahab
  • Journal    :RSC advances
  • Year         :2022

Dr. John Thometz|Pharmaceutical Analysis|Excellence in Reach Award

Published on by Top Pharmaceutical

Dr.JohnThometz|Pharmaceutical Analysis|Excellence in Reach Award

Dr. John Thometz at Medical College of WI,United States

PROFILE  

 

Scopus

🏫 Early Academic Pursuits

Dr. John G. Thometz embarked on his academic journey in medical sciences with a strong foundation at Northwestern University, where he earned a Bachelor of Science in Medicine (B.S.M.) in 1973. His commitment to global understanding in medicine took him to Loyola University in Rome, Italy, where he furthered his education in 1974. Dr. Thometz then completed his medical degree (M.D.) at Northwestern Medical School in 1978, after which he was awarded a surgical scholarship at Addenbrooke’s Hospital in Cambridge, England. These experiences laid the groundwork for his illustrious career in orthopedic surgery, with a specialization in pediatric orthopedics.

🩺 Professional Endeavors

Dr. Thometz’s professional career began with intensive training, including a general surgery internship at Loyola University in Chicago, followed by a residency in orthopedic surgery at Northwestern University. His desire to make an impact in pediatric orthopedics led him to Harvard University’s Children’s Hospital, where he completed a fellowship in 1985. Soon after, he joined the Medical College of Wisconsin, where he served as Assistant Professor in the Department of Orthopaedic Surgery. Over the years, his dedication and expertise were recognized with progressive appointments, eventually reaching the rank of Professor in 2000. Dr. Thometz has also held a long-standing role as Adjunct Professor at Marquette University’s Orthopaedic and Rehabilitation Engineering Center (OREC), bridging academic and clinical disciplines.

🔬 Contributions and Research Focus

Dr. Thometz’s research has significantly advanced pediatric orthopedics, with a focus on developing innovative treatments and technologies for children with musculoskeletal disorders. His research spans early-onset scoliosis, cerebral palsy, and spinal deformities. His projects include contributions to critical studies on casting versus bracing in scoliosis treatment, funded by the Orthopaedic Research and Education Foundation (OREF), and a novel study on dynamic pedorthosis for clubfoot correction. In collaboration with the U.S. Department of Health and Human Services and the National Institute on Disability and Rehabilitation Research (NIDILRR), Dr. Thometz has led initiatives to train physicians and engineers in advanced pediatric rehabilitation.

🏅 Accolades and Recognition

Dr. Thometz’s dedication to orthopedic surgery has been widely recognized through numerous accolades, highlighting his commitment to excellence in both teaching and clinical practice. He was named Teacher of the Year twice by the Medical College of Wisconsin’s Department of Orthopaedic Surgery (1988, 2000) and awarded the prestigious Louis A. Goldstein Award for Best Clinical Poster Presentation at the 2010 Scoliosis Research Society Annual Meeting. His expertise has also earned him a consistent place on the Best Doctors in America list, as well as recognition by MKE Lifestyle Magazine for multiple years, underscoring his impact in Milwaukee and beyond.

🌍 Impact and Influence

Beyond his immediate clinical and teaching roles, Dr. Thometz has made substantial contributions to the orthopedic community nationally and internationally. He is an active member and fellow of esteemed organizations, including the American Academy of Orthopaedic Surgeons, the Pediatric Orthopaedic Society of North America, and the Scoliosis Research Society. His work in these societies has focused on advancing pediatric orthopedics and influencing guidelines on nonoperative management strategies, particularly in scoliosis care.

🏛️ Legacy and Future Contributions

As a pioneer in pediatric orthopedic surgery, Dr. Thometz has contributed to foundational research and mentorship that continue to shape the field. His leadership as Medical Director of Pediatric Orthopedic Surgery at the Children’s Hospital of Wisconsin spanned three decades, culminating in his role as Emeritus Medical Director for the Spina Bifida program. Dr. Thometz’s work on advanced rehabilitation technologies and orthopedic interventions continues through his position as Co-Program Director of the Advanced Rehabilitation Research Training (ARRT) in Pediatric Mobility. His legacy is further carried on by his students and residents, many of whom have become leaders in orthopedics. Dr. Thometz’s future contributions are poised to focus on guiding new research, particularly in enhancing pediatric mobility and rehabilitation, with a continued commitment to improving the quality of life for children globally.

🎓Publication 

Analysis of adolescent idiopathic scoliosis population for Surgical Site Infection Risk Factors

  • Authors   :Fletcher, J., Liu, X.-C., Thometz, J.G.
  • Journal    :Journal of Orthopaedics
  • Year         :2025

Correlation of transverse rotation of the spine using surface topography and 3D reconstructive radiography in children with idiopathic scoliosis

  • Authors   : Patel, M., Liu, X.-C., Tassone, C., … Yang, K., Thometz, J.
  • Journal    :Spine Deformity
  • Year         :2024

3D Back Contour Metrics in Predicting Idiopathic Scoliosis Progression: Retrospective Cohort Analysis, Case Series Report and Proof of Concept

  • Authors   : Patel, M., Liu, X.-C., Yang, K., … Escott, B., Thometz, J.
  • Journal    :Children,
  • Year         :2024

Prophylactic Spinal Cord Untethering in Children with Spinal Dysraphism Undergoing Thoracolumbar Fusion for Scoliosis

  • Authors   :Bureau, B.L., Sherburne, E., Thometz, J.G., Foy, A.B.
  • Journal    :World Neurosurgery
  • Year         :2023

Preoperative left shoulder elevation > 1 cm is predictive of severe postoperative shoulder imbalance in early onset idiopathic scoliosis patients treated with growth-friendly instrumentation

  • Authors   :Li, Y., Yang, D., Bergman, R., … Yazici, M., Zhang, T.J.
  • Journal    :Spine Deformity
  • Year         :2023